FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAGILENT TECHNOLOGIES, INC.

Inspect →

AAAlcoa Corp

Inspect →

AAAUGoldman Sachs Physical Gold ETF

Inspect →

AACAres Acquisition Corp III

Inspect →

AACGATA Creativity Global

Inspect →

AACIArmada Acquisition Corp. III

Inspect →

AACOAbony Acquisition Corp. I

Inspect →

AACPApogee Acquisition Corp

Inspect →

AADXApplied Aerospace & Defense, Inc.

Inspect →

AAGHAmerica Great Health

Inspect →

AALAmerican Airlines Group Inc.

Inspect →

AAMEATLANTIC AMERICAN CORP

Inspect →

03 / FINANCIAL CHANGES

Ovid Therapeutics Inc. OVID

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-10 · Retrieved: 2026-11-13

Compared with the same period of the prior year, ending 2025-09-30.

Revenue0.00

USD million

Change year over year: -0.13 · -100.0%

Net income-20.78

USD million

Change year over year: -8.62

Operating cash flow-15.88

USD million

Change year over year: -3.01

Total liabilities23.57

USD million

Change year over year: +4.42

Total assets222.24

USD million

Change year over year: +158.40

Liabilities / assets: 10.6% · Change: -19.4 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-03-18 · Retrieved: 2026-11-13

Compared with the same period of the prior year, ending 2024-12-31.

Revenue7.25

USD million

Change year over year: +6.69 · +1,181.3%

Net income-17.41

USD million

Change year over year: +9.02

Operating cash flow-38.33

USD million

Change year over year: +17.62

Total liabilities20.27

USD million

Change year over year: -3.67

Total assets150.93

USD million

Change year over year: +58.77

Liabilities / assets: 13.4% · Change: -12.5 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
MNPR ↗	2025-12-31	0.00	—	—
ROIV ↗	2026-03-31	8.26	-3,629.2%	-9,084.1%
DCOY ↗	2025-12-31	—	—	—
AVIR ↗	2025-12-31	—	—	—
XENE ↗	2025-12-31	7.50	-4,612.1%	-3,721.6%
MAIA ↗	2025-12-31	—	—	—

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

ONDS ↗

Ondas Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

MNPR ↗

Monopar Therapeutics

Filed: 2026-11-12
Period ending: 2026-09-30

Latest annual report

RMR ↗

RMR GROUP INC.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

ITHUF ↗

iANTHUS CAPITAL HOLDINGS, INC.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

TECH ↗

BIO-TECHNE Corp

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

XAIR ↗

Beyond Air, Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

DCOY ↗

Decoy Therapeutics Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

HSDT ↗

Solana Co

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

KSCP ↗

Knightscope, Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

MNTR ↗

Mentor Capital, Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

SKYX ↗

SKYX Platforms Corp.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

GRNQ ↗

Greenpro Capital Corp.

Filed: 2026-11-12
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →